Andrew has advised Boards and shareholders on Healthcare M&A transactions for 20 years, as well as working as an operator in the sector. He leads Baird’s European Healthcare team as part of a global team of 50 healthcare advisors. His team advised on 7 completed European transactions in 2022 with a value of c.€1.5bn across healthcare services, pharma services and medical devices.